The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA

Molecular Biotechnology

Volumn 52, Issue 1, 2012, Pages 59-67

  Zhou, Gang ^a   Chiu, David ^a   Qin, Dajiang ^a   Niu, Lizhi ^a   Cai, Jinlei ^a   He, Lihua ^a   Huang, Wenhao ^a   Xu, Kecheng ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

CA199; CD44v6; CEA; Integrin 1; Pancreatic cancer

Indexed keywords

CA199; CD44V6; CEA; INTEGRINS; PANCREATIC CANCERS;

ANTIGENS; BODY FLUIDS; CARBOHYDRATES; CHEMOTHERAPY; CRYOSURGERY; GENES; PATHOLOGY; TRANSCRIPTION; TUMORS;

DISEASES;

BETA1 INTEGRIN; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 199; CARCINOEMBRYONIC ANTIGEN; CD44V6 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOSURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY;

ANTIGENS, CD29; ANTIGENS, CD44; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CRYOSURGERY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; TREATMENT OUTCOME;

EID: 84864047255     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-011-9474-7     Document Type: Article

References (42)

1. K Hirata S Egawa Y Kimura 2007 Current status of surgery for pancreatic cancer Digestive Surgery 24 3 137 141 10.1159/000102067
2. M Carpelan S Nordling 2005 Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry Gut 54 23 385 387 10.1136/gut.2004.047191
3. M Wagner C Redaelli M Lietz, et al. 2008 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma British Journal of Surgery 99 23 586 589
4. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics CA: A Cancer Journal for Clinicians 59 34 225 229 10.3322/caac.20006
5. JK Ryu SM Hong CA Karikari, et al. 2010 Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma Pancreatology 10 7 66 73 10.1159/000231984 1:CAS:528:DC%2BC3cXltVGisL4%3D
6. RO Hynes 1992 Integrins: versatility, modulation, and signaling in cell adhesion Cell 69 18 11 17 10.1016/0092-8674(92)90115-S 1:CAS:528: DyaK38XitFWmtrg%3D
7. H Gu C Ni R Zhan 2000 The expression of CD15 mRNA CD44v6 mRNA and nm23H1 mRNA in breast cancer and their clinical significance Zhonghua Yixue Zazhi 80 12 854 857 1:CAS:528:DC%2BD3MXmslel
8. GF Weber RT Bronston J Ilagan 2002 Absence of the CD44 gene prevents sarcoma metastasis Cancer Research 62 56 2281 2286 1:CAS:528: DC%2BD38Xjt1ejtbw%3D
9. FL Wang LX Wei 2001 Expression of CD44 variant exon 6 in lung cancers Zhongguo YixueKexueyuan Xuebao 23 45 401 402 1:CAS:528:DC%2BD3MXntVWisbw%3D
10. LR Ylagan J Scholes R Demopoulos, et al. 2000 Cd44: a marker of squamous differentiation in adenosquamous neoplasms Archives of Pathology and Laboratory Medicine 124 24 212 215 1:STN:280:DC%2BD3c7it1Wqsw%3D%3D
11. K Shimabukuro N Toyama-Sorimachi Y Ozaki, et al. 1997 The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer Gynecologic Oncology 64 33 26 34 10.1006/gyno.1996.4530 1:CAS:528:DyaK2sXoslKitg%3D%3D
12. K Jing S Qin L Zhi, et al. 2006 Expression of E-selectin, integrin-β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance World J Gastroenterology 12 2 3609 3611
13. ES Yao H Zhang YY Chen, et al. 2007 Increased beta1 integrin is associated with decreased survival in invasive breast cancer Cancer Research 67 42 659 664 10.1158/0008-5472.CAN-06-2768 1:CAS:528:DC%2BD2sXmtVKrsA%3D%3D
14. GY Yang KS Xu ZQ Pan, et al. 2008 Integrin α-β6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver Cancer Science 99 9 879 887 10.1111/j.1349-7006.2008.00762.x 1:CAS:528:DC%2BD1cXlslCrsb0%3D
15. M Wagner C Redaelli M Lietz 2008 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma British Journal of Surgery 86 12 586 890
16. T Okusaka A Funakoshi J Furuse, et al. 2007 A late phase II study of S1 for metastatic pancreatic cancer Cancer Chemotherapy and Pharmacology 87 123 578 582
17. H Yamazaki K Nishiyama M Koizumi, et al. 2007 Chemoradiotherapy for adcanced pancreatic cancer gemcitabine can be administered using limited-field radiotherapy Strahlentherapie und Onkologie 183 27 301 306 10.1007/s00066-007- 1641-1
18. KC Xu LZ Niu 2003 Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma World Journal of Gastroenterology 59 37 2686 2689
19. V Mouraviev TJ Polascik 2006 Update on cryotherapy for prostate cancer Current Opinion in Urology 16 67 152 156 10.1097/01.mou.0000193393.54598.9f
20. KC Xu LZ Niu 2003 Sequential treatment of transarterial chemoembolization percutaneous cryoablation for unresectable primary liver cancer World Journal of Gastroenterology 9 29 2688 2691
21. J Rautava T Soukka P Inki, et al. 2003 CD44v6 in developing, dysplastic and malignant oral epithelia Oral Oncology 39 33 373 379 10.1016/S1368-8375(02) 00140-9 1:CAS:528:DC%2BD3sXisV2rsLg%3D
22. DA Cheresh 1992 Strucural and biologic properties of integrinmediated cell adhesion Clinics in Laboratory Medicine 12 9 217 219 1:STN:280: DyaK38zgs1Gjsw%3D%3D
23. FJ Vizoso JC Fernández MD Corte, et al. 2004 Expression and clinical significance of CD44v5 and CD44v6 in resectable colorectal cancer Journal of Cancer Research and Clinical Oncology 130 35 679 680 10.1007/s00432-004-0596-1
24. K Yamamichi Y Uehara N Kitamura 1998 Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer Cancer 79 17 256 262 1:CAS:528:DyaK1cXjvF2rtL8%3D
25. M Fasano MT Sabatini 1997 CD44 and its v6 spliced variant in lung tumors: A role in histogenesis Cancer 88 18 34 41 10.1002/(SICI)1097-0142(19970701)80: 1<34::AID-CNCR5>3.0.CO;2-F
26. M Pignatelli AM Hanby GW Stamp 1991 Low expression of beta1, alpha2 and alpha3 subunits of VLA integrins in malignant mammary tumours Journal of Pathology 165 45 25 32 10.1002/path.1711650106 1:STN:280:DyaK38%2FmsFegtw%3D%3D
27. JA Eble J Haier 2006 Integrins in cancer treatment Curr Cancer Drug Target 6 19 89 95 10.2174/156800906776056518 1:CAS:528:DC%2BD28XislSmsLk%3D
28. T Klatte DB Seligson JY Rao 2010 Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome Journal of Urology 83 66 2403 2408 10.1016/j.juro.2010.01.064
29. H Saito S Tsujitani K Katano, et al. 1998 Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma Cancer 83 7 1094 1098 10.1002/(SICI)1097-0142(19980915)83:6<1094::AID- CNCR7>3.0.CO;2-8 1:STN:280:DyaK1cvhtVOruw%3D%3D
30. T Miyoshi K Konda 1997 The expression of the CD44 variant exon6 is associated with lymph node metastasis in non-small cell lung cancer Clinical Cancer Research 3 10 1289 1292 1:CAS:528:DyaK2sXls1Smtrs%3D
31. Y Du C Yang X Zhang, et al. 2008 Expression and significance of integrin beta1 and integrin-linked kinase in laryngeal carcinoma Lin Chuang Er Bi Yan Hou Jing Wai Ke Za Zhi 22 23 500 503
32. F Chi Z Wang 2010 Expression of integrin beta1 in human gastric cardia adenocarcinoma tissues and their correlations with clinicalpathological significance Chin J Cancer Prev Treat 17 27 752 754 1:CAS:528:DC%2BC3cXhtlGgsLrK
33. CC Park H Zhang M Pallavicini, et al. 2006 Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo Cancer Research 66 22 15 26
34. T Klatte DB Seligson JY Rao, et al. 2010 Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome Journal of Urology 183 22 2403 2408 10.1016/j.juro.2010.01.064 1:CAS:528: DC%2BC3cXns1yktbg%3D
35. H Saito S Tsujitani 1998 Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma Cancer 83 112 1094 1098 10.1002/(SICI)1097-0142(19980915)83:6<1094::AID-CNCR7>3.0.CO;2-8 1:STN:280:DyaK1cvhtVOruw%3D%3D
36. L Ju C Zhou W Li 2009 Effect of integrin β1 up-regulation on the migration and adhesion capacity of lung cancer cell Progress in Modern Biomedicine 9 29 3807 3812 1:CAS:528:DC%2BC3cXjsFOjur8%3D
37. Y Zhang 2005 The relation between CD44 and tumor development Journal of Chinese Medical 22 56 343 346
38. CM Kang JY Kim GH Choi, et al. 2007 The use of adjusted preoperative CA19-9 to predict the recurrence of resectable pancreatic cancer Journal of Surgical Research 140 1 31 35 10.1016/j.jss.2006.10.007 1:CAS:528: DC%2BD2sXkvFOqsrs%3D
39. E Giannini P Borro F Botta, et al. 2001 Cholestasis is the main determinant of abnormal CA199 levels in patients with pancreatic cancer International Journal of Biological Markers 15 55 126 129
40. JT Jiang CP Wu HF Deng, et al. 2004 Serum Level of CEA, CA242 and CA199 in pancreatic cancer World Journal of Gastroenterology 10 11 1675 1679 1:CAS:528:DC%2BD2cXlsFWgtrw%3D
41. SJ Kovach RJ Hendrickson 2002 Cryoablation of unresectable pancreatic cancer Surgery 131 31 463 465 10.1067/msy.2002.121231
42. Korpan, N. N. (2001). Pancreas cryosurgery. In N. N. Korpan (Ed.), Basics of Cryosurgery (1st ed.). Wein, NY: Springer-Verlag.